Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edaravone Dexborneol in Hypertensive Intracerebral Hemorrhage
NCT04714177Phase 2Unknown
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Mar 2021
- Primary completion
- Mar 2023
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of edaravone dexborneol in intraparenchymal hematoma (IPH), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Status: unknown.
02
Drugs
edaravone dexborneol
03
Conditions
intraparenchymal hematoma (IPH)
Beyond the preview
Go deeper on NCT04714177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04714177.